These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 8176105)

  • 61. Relation of left ventricular midwall function to cardiovascular risk factors and arterial structure and function.
    Devereux RB; de Simone G; Pickering TG; Schwartz JE; Roman MJ
    Hypertension; 1998 Apr; 31(4):929-36. PubMed ID: 9535417
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up.
    Muiesan ML; Salvetti M; Rizzoni D; Monteduro C; Castellano M; Agabiti-Rosei E
    J Hypertens Suppl; 1996 Dec; 14(5):S43-9. PubMed ID: 9120684
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of midwall systolic function in left ventricular hypertrophy: a comparison of 3-dimensional versus 2-dimensional echocardiographic indices.
    Jung HO; Sheehan FH; Bolson EL; Waiss MP; Otto CM
    J Am Soc Echocardiogr; 2006 Jun; 19(6):802-10. PubMed ID: 16762760
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease.
    Cioffi G; Viapiana O; Ognibeni F; Dalbeni A; Gatti D; Mazzone C; Faganello G; Di Lenarda A; Adami S; Rossini M
    J Am Soc Echocardiogr; 2016 Jul; 29(7):689-98. PubMed ID: 26922258
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Left ventricular adaptation to hypertension and plasma renin activity.
    du Cailar G; Pasquié JL; Ribstein J; Mimran A
    J Hum Hypertens; 2000 Mar; 14(3):181-8. PubMed ID: 10694832
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association of hemoglobin delivery with left ventricular structure and function in hypertensive patients: Losartan Intervention for End Point Reduction in Hypertension Study.
    Narayan P; Papademetriou V; Wachtell K; Gerdts E; Boman K; Nieminen MS; de Simone G; Dahlöf B; Fyhrquist F; Hoieggen A; Devereux RB
    Hypertension; 2006 May; 47(5):868-73. PubMed ID: 16567586
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Additive Prognostic Value of Left Ventricular Systolic Dysfunction in a Population-Based Cohort.
    Kuznetsova T; Cauwenberghs N; Knez J; Yang WY; Herbots L; D'hooge J; Haddad F; Thijs L; Voigt JU; Staessen JA
    Circ Cardiovasc Imaging; 2016 Jul; 9(7):. PubMed ID: 27329778
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Left ventricular diastolic function in hypertension: relation to left ventricular mass and systolic function.
    Fouad FM; Slominski JM; Tarazi RC
    J Am Coll Cardiol; 1984 Jun; 3(6):1500-6. PubMed ID: 6232306
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Left atrial function and ventricular filling in hypertensive patients with paroxysmal atrial fibrillation.
    Barbier P; Alioto G; Guazzi MD
    J Am Coll Cardiol; 1994 Jul; 24(1):165-70. PubMed ID: 8006261
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Supernormal contractility in primary hypertension without left ventricular hypertrophy.
    de Simone G; Di Lorenzo L; Costantino G; Moccia D; Buonissimo S; de Divitiis O
    Hypertension; 1988 May; 11(5):457-63. PubMed ID: 2966769
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Change in systolic left ventricular performance after 3 years of antihypertensive treatment: the Losartan Intervention for Endpoint (LIFE) Study.
    Wachtell K; Palmieri V; Olsen MH; Gerdts E; Papademetriou V; Nieminen MS; Smith G; Dahlöf B; Aurigemma GP; Devereux RB
    Circulation; 2002 Jul; 106(2):227-32. PubMed ID: 12105163
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Midwall left ventricular performance in salt-loaded Dahl rats: effect of AT1 angiotensin II inhibition.
    de Simone G; Devereux RB; Camargo MJ; Wallerson DC; Sealey JE; Laragh JH
    J Hypertens; 1995 Dec; 13(12 Pt 2):1808-12. PubMed ID: 8903657
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Roman MJ; Køber L; Wachtell K; Devereux RB
    J Hypertens; 2013 Oct; 31(10):2060-8. PubMed ID: 23838656
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A new method to estimate left ventricular circumferential midwall systolic function by standard echocardiography: Concordance between models and validation by speckle tracking.
    Ballo P; Nistri S; Bocelli A; Mele D; Dini FL; Galderisi M; Zuppiroli A; Mondillo S
    Int J Cardiol; 2016 Jan; 203():947-58. PubMed ID: 26625318
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Rationale of echocardiographic assessment of left ventricular wall stress and midwall mechanics in hypertensive heart disease.
    de Simone G; Devereux RB
    Eur J Echocardiogr; 2002 Sep; 3(3):192-8. PubMed ID: 12144838
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Influence of microalbuminuria on left ventricular geometry and function in hypertensive patients with type 2 diabetes mellitus.
    Picca M; Agozzino F; Pelosi G
    Ital Heart J; 2003 Jan; 4(1):48-52. PubMed ID: 12690921
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure.
    Litwin SE; Katz SE; Weinberg EO; Lorell BH; Aurigemma GP; Douglas PS
    Circulation; 1995 May; 91(10):2642-54. PubMed ID: 7743628
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Marked regional left ventricular heterogeneity in hypertensive left ventricular hypertrophy patients: a losartan intervention for endpoint reduction in hypertension (LIFE) cardiovascular magnetic resonance and echocardiographic substudy.
    Biederman RW; Doyle M; Young AA; Devereux RB; Kortright E; Perry G; Bella JN; Oparil S; Calhoun D; Pohost GM; Dell'Italia LJ
    Hypertension; 2008 Aug; 52(2):279-86. PubMed ID: 18606908
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of increased wall thickness on indices of left ventricular pump function in children.
    Wessel A; Schüller WC; Yelbuz TM; Bürsch JH
    Br Heart J; 1994 Aug; 72(2):182-5. PubMed ID: 7917694
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Left ventricular hypertrophy and geometric remodeling in hypertension: stimuli, functional consequences and prognostic implications.
    Devereux RB; de Simone G; Ganau A; Roman MJ
    J Hypertens Suppl; 1994 Dec; 12(10):S117-27. PubMed ID: 7769482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.